Clinical and radiographic evaluation of Endoflas” versus Zinc Oxide and Eugenol” as root canal filling material in primary molars: A randomized controlled trial.
Phase 4
Completed
- Conditions
- pulpectomy in vital primary molarsOral Health
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
Cooperative patients with age range 4-7 years.
Vital tooth with carious pulp exposure, diagnosed as having irreversible pulpitis on basis of reported symptoms and/or
clinical findings. (eg. profuse hemorrhage following pulpotomy procedure).
Restorable tooth.
Tooth with at least two-third of intact root length.
Informed consent was obtained from each patient.
Exclusion Criteria
Patients with systemic diseases.
Patients refused follow up protocol.
Tooth with preshedding and abnormal pathologic mobility.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of Endoflas in root canal treatment for primary molars?
How does the effectiveness of Endoflas compare to Zinc Oxide and Eugenol in primary molar pulpectomies?
Are there specific biomarkers that predict successful outcomes with Endoflas in pediatric dentistry?
What are the potential adverse events associated with Endoflas as a root canal filling material?
What alternative root canal filling materials are being studied for primary molars alongside Endoflas?